✦ LIBER ✦

Caf versus caf plus medroxyprogesterone acetate for treatment of liver metastases of breast cancer

✍ Scribed by Tomio Wada; Kouichiro Nishiyama; Yoshihiro Nakatani; Toshiya Houjou; Hiroki Inui; Eiju Yamauchi; Satoshi Hara; Masayuki Yasutomi

Book ID: 112956119
Publisher: Springer Japan
Year: 1995
Tongue: English
Weight: 498 KB
Volume: 2
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02966898

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful management of breast cancer w

Successful management of breast cancer with liver metastases with medroxyprogesterone acetate treatment

✍ T. Toyama; H. Yamashita; Y. Hara; Y. Hikosaka; S. Kobayashi; H. Iwase 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 56 KB

4 Megestrol acetate versus medroxyproges

4 Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastatic breast cancer

✍ H.-E. Wander; U.R. Kleeberg; E. Gärtner; J. Hartlapp; A. Scherpe; E. Bönisch; G. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Conventional dose CAF therapy versus low

Conventional dose CAF therapy versus low dose adriamycin therapy in the treatment of advanced breast cancer

✍ Tomio Wada; Eiju Yamauchi; Kouichiro Nishiyama; Yoshihiro Nakatani; Toshiya Houj 📂 Article 📅 1994 🏛 Springer Japan 🌐 English ⚖ 499 KB

Liver Resection for Multimodal Treatment

Liver Resection for Multimodal Treatment of Breast Cancer Metastases: Identification of Prognostic Factors

✍ Katrin Hoffmann; Clemens Franz; Ulf Hinz; Peter Schirmacher; Christian Herfarth; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 306 KB

Pharmacokinetic and pharmacodynamic basi

Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate

✍ Hans Christian Blossey; Hans Erik Wander; Johannes Koebberling; Professor Dr. Ge 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 728 KB

Postmenopausal patients with metastatic breast cancer were treated with medroxyprogesterone acetate (MPA) (Clinovir) in dosages between 500 and 1500 mg orally per day. The relation of MPA plasma concentrations and endocrine effects were studied in a longitudinal fashion. MPA exerted suppressive effe

536 High dose medroxyprogesterone acetat

536 High dose medroxyprogesterone acetate (MPA)in combination with chemotherapy for treatment of advanced breast cancer

✍ G.Robustelli Delia Cuna; A. Pellegrini 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 112 KB